Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Nuclear Medicine

Free Subscription Articles published in Ann Nucl Med Retrieve available abstracts of 256 articles: HTML format

Single Articles

April 2024
1. SUNG C, Oh JS, Park BS, Kim SS, et al
   Diagnostic performance of a deep-learning model using (18)F-FDG PET/CT for evaluating recurrence after radiation therapy in patients with lung cancer.
   Ann Nucl Med. 2024 Apr 8. doi: 10.1007/s12149-024-01925.
   PubMed     Abstract available
   
   
   
2. HOSSEINI SA, Shiri I, Ghaffarian P, Hajianfar G, et al
   The effect of harmonization on the variability of PET radiomic features extracted using various segmentation methods.
   Ann Nucl Med. 2024 Apr 4. doi: 10.1007/s12149-024-01923.
   PubMed     Abstract available
   
   
   
3. GUO H, Wu S, Xiang X, Wang S, et al
   Performance of (99m)Tc-PYP scintigraphy in the diagnosis of hereditary transthyretin cardiac amyloidosis.
   Ann Nucl Med. 2024;38:288-295.
   PubMed     Abstract available
   
   
   March 2024
4. JIN L, Zhang L, Fu L, Song F, et al
   18F-FDG PET/CT metabolism multi-parameter prediction of chemotherapy efficacy in locally progressive gastric cancer.
   Ann Nucl Med. 2024 Mar 27. doi: 10.1007/s12149-024-01921.
   PubMed     Abstract available
   
   
   
5. FUKAI S, Daisaki H, Umeda T, Shimada N, et al
   Evaluation of two-dimensional total bone uptake (2D-TBU) and bone scan index (BSI) extracted from active bone metastatic burden on the bone scintigraphy in patients with radium-223 treatment.
   Ann Nucl Med. 2024 Mar 22. doi: 10.1007/s12149-024-01918.
   PubMed     Abstract available
   
   
   
6. SHANG C, Sakurai K, Nihashi T, Arahata Y, et al
   Comparison of consistency in centiloid scale among different analytical methods in amyloid PET: the CapAIBL, VIZCalc, and Amyquant methods.
   Ann Nucl Med. 2024 Mar 21. doi: 10.1007/s12149-024-01919.
   PubMed     Abstract available
   
   
   
7. LEE K, Han S, Ryu J, Cho SG, et al
   Prognostic value of left ventricular mechanical dyssynchrony indices derived from gated myocardial perfusion SPECT in coronary artery disease: a systematic review and meta-analysis.
   Ann Nucl Med. 2024 Mar 18. doi: 10.1007/s12149-024-01915.
   PubMed     Abstract available
   
   
   
8. MARUO A, Magota K, Munakata Y, Hirata K, et al
   Improvement in the estimation of perfusable tissue fraction and myocardial flow reserve in the ischemic myocardial lesions using ECG-gated dynamic myocardial PET with (15)O-water.
   Ann Nucl Med. 2024 Mar 13. doi: 10.1007/s12149-024-01913.
   PubMed     Abstract available
   
   
   
9. ZHANG X, Nakajima K, Mizokami A, Horikoshi H, et al
   Flare phenomenon visualized by (99m)Tc-bone scintigraphy has prognostic value for patients with metastatic castration-resistant prostate cancer.
   Ann Nucl Med. 2024 Mar 13. doi: 10.1007/s12149-024-01914.
   PubMed     Abstract available
   
   
   
10. WAGATSUMA K, Ikemoto K, Inaji M, Kamitaka Y, et al
    Impact of [(11)C]methionine PET with Bayesian penalized likelihood reconstruction on glioma grades based on new WHO 2021 classification.
    Ann Nucl Med. 2024 Mar 11. doi: 10.1007/s12149-024-01911.
    PubMed     Abstract available
    
    
    
11. MIYAMOTO M, Okuyama C, Kagawa S, Kusano K, et al
    Correction: Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects.
    Ann Nucl Med. 2024 Mar 7. doi: 10.1007/s12149-024-01917.
    PubMed    
    
    
    
12. OZUTEMIZ C, Koksel Y, Froelich JW, Rubin N, et al
    The active papillary muscle sign in 18F-FDG PET/CT cardiac sarcoidosis exams and its relationship with myocardial suppression.
    Ann Nucl Med. 2024 Mar 2. doi: 10.1007/s12149-024-01910.
    PubMed     Abstract available
    
    
    
13. NOIPINIT N, Sukprakun C, Siricharoen P, Khamwan K, et al
    Comparison of absorbed doses to the tumoral and non-tumoral liver in HCC patients undergoing (99m)Tc-MAA and (90)Y-microspheres radioembolization.
    Ann Nucl Med. 2024;38:210-218.
    PubMed     Abstract available
    
    
    February 2024
14. OKIZAKI A, Nishiyama Y, Inui Y, Otsuka H, et al
    Nuclear medicine practice in Japan: a report of the ninth nationwide survey in 2022.
    Ann Nucl Med. 2024 Feb 29. doi: 10.1007/s12149-024-01905.
    PubMed     Abstract available
    
    
    
15. KANEKO K, Nagao M, Ueda K, Yamamoto A, et al
    Simultaneous evaluation of brain metastasis and thoracic cancer using semiconductor (11)C-methionine PET/CT imaging.
    Ann Nucl Med. 2024 Feb 22. doi: 10.1007/s12149-024-01908.
    PubMed     Abstract available
    
    
    
16. HONG Z, Xu H, Ni K, Yang Y, et al
    Effect of Cyclosporin H on ischemic injury and neutrophil infiltration in cerebral infarct model of rats via PET imaging.
    Ann Nucl Med. 2024 Feb 15. doi: 10.1007/s12149-024-01900.
    PubMed     Abstract available
    
    
    
17. NIITSU H, Fukumitsu N, Tanaka K, Mizumoto M, et al
    Methyl-(11)C-L-methionine positron emission tomography for radiotherapy planning for recurrent malignant glioma.
    Ann Nucl Med. 2024 Feb 14. doi: 10.1007/s12149-024-01901.
    PubMed     Abstract available
    
    
    
18. AMIRI A, Fazaeli Y, Zare H, Eslami-Kalantari M, et al
    Radiolabeled florescent-magnetic graphene oxide nanosheets: probing the biodistribution of a potential PET-MRI hybrid imaging agent for detection of fibrosarcoma tumor.
    Ann Nucl Med. 2024 Feb 12. doi: 10.1007/s12149-024-01902.
    PubMed     Abstract available
    
    
    
19. SINGHAL T, Singh P, Parida GK, Agrawal K, et al
    Role of PSMA-targeted PET-CT in renal cell carcinoma: a systematic review and meta-analysis.
    Ann Nucl Med. 2024 Feb 10. doi: 10.1007/s12149-024-01904.
    PubMed     Abstract available
    
    
    
20. MARUYAMA H, Gomi M, Lwin TT, Yoneyama A, et al
    [(18)F]-FDG uptake in brain slices prepared from an aged mouse model of Alzheimer's disease using a dynamic autoradiography technique.
    Ann Nucl Med. 2024;38:120-130.
    PubMed     Abstract available
    
    
    January 2024
21. TAMURA K, Nishii R, Tani K, Hashimoto H, et al
    A first-in-man study of [(18)F] FEDAC: a novel PET tracer for the 18-kDa translocator protein.
    Ann Nucl Med. 2024 Jan 29. doi: 10.1007/s12149-023-01895.
    PubMed     Abstract available
    
    
    
22. SINGH SB, Bhandari S, Bhandari S, Bhandari S, et al
    Role of PET/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review.
    Ann Nucl Med. 2024 Jan 26. doi: 10.1007/s12149-023-01896.
    PubMed     Abstract available
    
    
    
23. HOTTA M, Sonni I, Thin P, Nguyen K, et al
    Visual and whole-body quantitative analyses of (68) Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with (177)Lu-DOTATATE.
    Ann Nucl Med. 2024 Jan 22. doi: 10.1007/s12149-023-01899.
    PubMed     Abstract available
    
    
    
24. DERAKHSHAN S, Ghaderi B, Roshani D
    Left ventricular mechanical dyssynchrony after chemotherapy in breast cancer patients with normal rest gated SPECT-MPI.
    Ann Nucl Med. 2024 Jan 20. doi: 10.1007/s12149-023-01897.
    PubMed     Abstract available
    
    
    
25. AN R, Ma X, Wang Y
    The value of 18F-FDG PET/CT in Langerhans cell histiocytosis.
    Ann Nucl Med. 2024 Jan 13. doi: 10.1007/s12149-023-01892.
    PubMed     Abstract available
    
    
    
26. LI T, Dou J, Zhang H, Su X, et al
    Optimized gated a SPECT-derived myocardial salvage index: its prognostic significance in predicting major adverse cardiac events following acute myocardial infarction percussion.
    Ann Nucl Med. 2024 Jan 4. doi: 10.1007/s12149-023-01894.
    PubMed     Abstract available
    
    
    
27. TAMAKI N, Manabe O
    Current status and perspectives of nuclear cardiology.
    Ann Nucl Med. 2024;38:20-30.
    PubMed     Abstract available
    
    
    
28. NAKAJIMA K, Miyauchi H, Hirano KI, Fujimoto S, et al
    Practice recommendation for measuring washout rates in (123)I-BMIPP fatty acid images.
    Ann Nucl Med. 2024;38:1-8.
    PubMed     Abstract available
    
    
    December 2023
29. KAWAKUBO M, Nagao M, Kaimoto Y, Nakao R, et al
    Deep learning approach using SPECT-to-PET translation for attenuation correction in CT-less myocardial perfusion SPECT imaging.
    Ann Nucl Med. 2023 Dec 28. doi: 10.1007/s12149-023-01889.
    PubMed     Abstract available
    
    
    
30. LIN JT, Li XM, Zhong WZ, Hou QY, et al
    Impact of preoperative [(18)F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study.
    Ann Nucl Med. 2023 Dec 25. doi: 10.1007/s12149-023-01888.
    PubMed     Abstract available
    
    
    
31. CUI FB, Lv X, Yan CL, Eng WS, et al
    Development and application of a fully automatic multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis.
    Ann Nucl Med. 2023 Dec 25. doi: 10.1007/s12149-023-01893.
    PubMed     Abstract available
    
    
    November 2023
32. PACELLA S, Grappeja L
    Prognostic value of pre-treatment 18F-FDG PET/CT parameters in endometrial cancer.
    Ann Nucl Med. 2023 Nov 27. doi: 10.1007/s12149-023-01887.
    PubMed    
    
    
    
33. SHINOHARA Y, Ibaraki M, Matsubara K, Sato K, et al
    Visualization of small brain nuclei with a high-spatial resolution, clinically available whole-body PET scanner.
    Ann Nucl Med. 2023 Nov 21. doi: 10.1007/s12149-023-01886.
    PubMed     Abstract available
    
    
    
34. SANAAT A, Amini M, Arabi H, Zaidi H, et al
    The quest for multifunctional and dedicated PET instrumentation with irregular geometries.
    Ann Nucl Med. 2023 Nov 12. doi: 10.1007/s12149-023-01881.
    PubMed     Abstract available
    
    
    
35. PERERA MOLLIGODA ARACHCHIGE AS
    Assessing dedicated breast PET performance in breast cancer screening alongside digital mammography, digital breast tomosynthesis, and ultrasound: a reader's insight.
    Ann Nucl Med. 2023 Nov 9. doi: 10.1007/s12149-023-01882.
    PubMed    
    
    
    
36. WATANABE S, Hirata K, Magota K, Takenaka J, et al
    Comparative study of physiological FDG uptake in small structures between silicon photomultiplier-based PET and conventional PET.
    Ann Nucl Med. 2023 Nov 9. doi: 10.1007/s12149-023-01884.
    PubMed     Abstract available
    
    
    
37. SHAMIM SA, Kumar N, Arora G, Jaswal S, et al
    A prospective study of (68)Ga-PSMA PET/CT imaging of HCC as diagnosed on conventional imaging to evaluate for potential (177)Lu-PSMA therapy.
    Ann Nucl Med. 2023 Nov 6. doi: 10.1007/s12149-023-01876.
    PubMed     Abstract available
    
    
    October 2023
38. MICHALSKI K, Kosmala A, Werner RA, Serfling SE, et al
    Comparison of PET/CT-based eligibility according to VISION and TheraP trial criteria in end-stage prostate cancer patients undergoing radioligand therapy.
    Ann Nucl Med. 2023 Oct 27. doi: 10.1007/s12149-023-01874.
    PubMed     Abstract available
    
    
    
39. NAKAMOTO Y, Baba S, Kaida H, Manabe O, et al
    Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects.
    Ann Nucl Med. 2023 Oct 20. doi: 10.1007/s12149-023-01873.
    PubMed     Abstract available
    
    
    
40. MAKINO A, Kume K, Mori T, Tsujikawa T, et al
    High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early stage treatment effect using 3'-deoxy-3'-[(18)F]fluorothymidine positron emission tomography.
    Ann Nucl Med. 2023 Oct 19. doi: 10.1007/s12149-023-01877.
    PubMed     Abstract available
    
    
    
41. NITTA N, Yoshimatsu R, Iwasa H, Nakaji K, et al
    Difference in arterial FDG accumulation in healthy study participants between digital PET/CT and standard PET/CT.
    Ann Nucl Med. 2023 Oct 18. doi: 10.1007/s12149-023-01875.
    PubMed     Abstract available
    
    
    
42. MIYAJI N, Miwa K, Yamashita K, Motegi K, et al
    Impact of irregular waveforms on data-driven respiratory gated PET/CT images processed using MotionFree algorithm.
    Ann Nucl Med. 2023 Oct 5. doi: 10.1007/s12149-023-01870.
    PubMed     Abstract available
    
    
    
43. LIU C, Ma G, Zhang J, Cheng J, et al
    (18)F-FES and (18)F-FDG PET/CT imaging as a predictive biomarkers for metastatic breast cancer patients undergoing cyclin-dependent 4/6 kinase inhibitors with endocrine treatment.
    Ann Nucl Med. 2023 Oct 3. doi: 10.1007/s12149-023-01871.
    PubMed     Abstract available
    
    
    
44. GUNER LA, Unal K, Beylergil V, Tuna MB, et al
    Enhancing PSMA PET/CT imaging of prostate cancer: investigating the impact of multiple time point evaluation, diuretic administration, cribriform pattern, and intraductal carcinoma.
    Ann Nucl Med. 2023 Oct 3. doi: 10.1007/s12149-023-01864.
    PubMed     Abstract available
    
    
    September 2023
45. SADEGHI MH, Sina S, Alavi M, Giammarile F, et al
    The OCDA-Net: a 3D convolutional neural network-based system for classification and staging of ovarian cancer patients using [(18)F]FDG PET/CT examinations.
    Ann Nucl Med. 2023 Sep 28. doi: 10.1007/s12149-023-01867.
    PubMed     Abstract available
    
    
    
46. KIDERA E, Koyasu S, Hirata K, Hamaji M, et al
    Convolutional neural network-based program to predict lymph node metastasis of non-small cell lung cancer using (18)F-FDG PET.
    Ann Nucl Med. 2023 Sep 27. doi: 10.1007/s12149-023-01866.
    PubMed     Abstract available
    
    
    
47. HIRATA K, Kamagata K, Ueda D, Yanagawa M, et al
    From FDG and beyond: the evolving potential of nuclear medicine.
    Ann Nucl Med. 2023 Sep 25. doi: 10.1007/s12149-023-01865.
    PubMed     Abstract available
    
    
    
48. SUN X, Yao X, Zeng B, Zhu L, et al
    Association of mismatch repair deficiency in endometrial cancer with (18)F-FDG PET/CT and clinicopathological features and their prognostic value.
    Ann Nucl Med. 2023 Sep 24. doi: 10.1007/s12149-023-01869.
    PubMed     Abstract available
    
    
    
49. LIU Z, Daniels T, Campen MJ, Alvidrez RIM, et al
    Inflammatory atherosclerotic plaque identification by SPECT/CT imaging of LFA-1 using [(111)In] In-DANBIRT in a novel dyslipidemic rat model.
    Ann Nucl Med. 2023 Sep 24. doi: 10.1007/s12149-023-01868.
    PubMed     Abstract available
    
    
    
50. SADAGHIANI MS, Roman S, Wang Y, Rowe SP, et al
    Assessment of anti-GAD65-associated cerebellar ataxia with (18)F-FDG cerebellar uptake: ROC analysis.
    Ann Nucl Med. 2023;37:528-534.
    PubMed     Abstract available
    
    
    August 2023
51. CUI N, Li J, Jiang Z, Long Z, et al
    Development and validation of (18)F-FDG PET/CT radiomics-based nomogram to predict visceral pleural invasion in solid lung adenocarcinoma.
    Ann Nucl Med. 2023 Aug 20. doi: 10.1007/s12149-023-01861.
    PubMed     Abstract available
    
    
    
52. LUCAS LUCAS C, Garcia Zoghby L, Amo-Salas M, Soriano Castrejon AM, et al
    Diagnostic and therapeutic impact of PET/CT with 18F-DCFPyL versus 18F-Fluorocholine in initial staging of intermediate-/high-risk prostate cancer: a pilot study.
    Ann Nucl Med. 2023 Aug 2. doi: 10.1007/s12149-023-01859.
    PubMed     Abstract available
    
    
    
53. OHASHI K, Iguchi H, Nagatani Y, Kobashi K, et al
    Usefulness of preset count acquisition in pediatric (99m) Tc-DMSA planar imaging.
    Ann Nucl Med. 2023;37:470-477.
    PubMed     Abstract available
    
    
    July 2023
54. KATO T, Ichikawa H, Shibutani T, Kita A, et al
    A novel objective method for discriminating pathological and physiological colorectal uptake in the lower abdominal region using whole-body dynamic (18)F-FDG-PET.
    Ann Nucl Med. 2023 Jul 31. doi: 10.1007/s12149-023-01857.
    PubMed     Abstract available
    
    
    
55. CHOI K, Park JS, Kwon YS, Park SH, et al
    Development of lung cancer risk prediction models based on F-18 FDG PET images.
    Ann Nucl Med. 2023 Jul 17. doi: 10.1007/s12149-023-01858.
    PubMed     Abstract available
    
    
    
56. LI X, Wang L, Guo P, Sun Q, et al
    Diagnostic performance of noninvasive imaging using computed tomography, magnetic resonance imaging, and positron emission tomography for the detection of ovarian cancer: a meta-analysis.
    Ann Nucl Med. 2023 Jul 9. doi: 10.1007/s12149-023-01856.
    PubMed     Abstract available
    
    
    
57. MANABE O, Takahashi K, Kawakami H, Ohtsuka A, et al
    Diagnostic values of delayed additional FDG PET/CT scan in the evaluation of cardiac sarcoidosis.
    Ann Nucl Med. 2023 Jul 7. doi: 10.1007/s12149-023-01855.
    PubMed     Abstract available
    
    
    
58. KUDO A, Fujimoto S, Aoshima C, Kawaguchi YO, et al
    First validation of stress myocardial perfusion scintigraphy using a novel reconstruction process.
    Ann Nucl Med. 2023;37:390-399.
    PubMed     Abstract available
    
    
    June 2023
59. EVANGELISTA L, Filippi L, Schillaci O
    What radiolabeled FAPI pet can add in breast cancer? A systematic review from literature.
    Ann Nucl Med. 2023 Jun 21. doi: 10.1007/s12149-023-01852.
    PubMed     Abstract available
    
    
    
60. GUZEL Y, Komek H, Can C, Kaplan I, et al
    Role of volumetric parameters obtained from (68) Ga-PSMA PET/CT and (18)F-FDG PET/CT in predicting overall survival in patients with mCRPC receiving taxane therapy.
    Ann Nucl Med. 2023 Jun 18. doi: 10.1007/s12149-023-01854.
    PubMed     Abstract available
    
    
    
61. YUGE S, Miyake KK, Ishimori T, Kataoka M, et al
    Performance of dedicated breast PET in breast cancer screening: comparison with digital mammography plus digital breast tomosynthesis and ultrasound.
    Ann Nucl Med. 2023 Jun 6. doi: 10.1007/s12149-023-01846.
    PubMed     Abstract available
    
    
    
62. XIE H, Zhao Z, Zhang W, Li L, et al
    Quantitative analysis of lung function and airway remodeling using ventilation/perfusion single photon emission tomography/computed tomography and HRCT in patients with chronic obstructive pulmonary disease and asthma.
    Ann Nucl Med. 2023 Jun 3. doi: 10.1007/s12149-023-01848.
    PubMed     Abstract available
    
    
    
63. NAKAJIMA K, Nishimura T
    J-ACCESS investigation and nuclear cardiology in Japan: implications for heart failure.
    Ann Nucl Med. 2023;37:317-327.
    PubMed     Abstract available
    
    
    May 2023
64. KANEKO K, Nagao M, Yamamoto A, Sakai A, et al
    Correction: Linking cardiac and extracardiac sarcoidosis and their clinical outcome: (18)F-FDG PET/CT analysis in patients with systemic cardiac sarcoidosis.
    Ann Nucl Med. 2023 May 30. doi: 10.1007/s12149-023-01850.
    PubMed    
    
    
    
65. WAGATSUMA K, Miwa K, Akamatsu G, Yamao T, et al
    Toward standardization of tau PET imaging corresponding to various tau PET tracers: a multicenter phantom study.
    Ann Nucl Med. 2023 May 27. doi: 10.1007/s12149-023-01847.
    PubMed     Abstract available
    
    
    
66. TADA T, Hara K, Fujita N, Ito Y, et al
    Comparative examination of the pons and corpus callosum as reference regions for quantitative evaluation in positron emission tomography imaging for Alzheimer's disease using (11)C-Pittsburgh Compound-B.
    Ann Nucl Med. 2023 May 9. doi: 10.1007/s12149-023-01843.
    PubMed     Abstract available
    
    
    
67. OGASAWARA K, Takahashi T, Igarashi S, Yabuki M, et al
    Effect of the addition of (123)I-iomazenil single-photon emission computed tomography to brain perfusion single-photon emission computed tomography on the detection accuracy of misery perfusion in adult patients with ischemic moyamoya disease.
    Ann Nucl Med. 2023;37:280-288.
    PubMed     Abstract available
    
    
    April 2023
68. KANEKO K, Nagao M, Yamamoto A, Sakai A, et al
    Linking cardiac and extracardiac sarcoidosis and their clinical outcome: (18)F-FDG PET/CT analysis in patients with systemic cardiac sarcoidosis.
    Ann Nucl Med. 2023 Apr 29. doi: 10.1007/s12149-023-01844.
    PubMed     Abstract available
    
    
    
69. MCDONALD EO, Amanullah AA, Park PSU, Song W, et al
    The role of (18)F-FDG PET/CT in primary cutaneous lymphoma: an educational review.
    Ann Nucl Med. 2023 Apr 24. doi: 10.1007/s12149-023-01830.
    PubMed     Abstract available
    
    
    
70. MATSUNAGA K, Tonomura M, Abe K, Shimosegawa E, et al
    Effect of scan-time shortening on the (11)C-PHNO binding potential to dopamine D(3) receptor in humans and test-retest reliability.
    Ann Nucl Med. 2023;37:227-237.
    PubMed     Abstract available
    
    
    March 2023
71. NORIKANE T, Yamamoto Y, Takami Y, Murao M, et al
    Feasibility of whole-body 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography angiography using continuous bed motion in patients with vascular disease: a pilot study.
    Ann Nucl Med. 2023 Mar 31. doi: 10.1007/s12149-023-01835.
    PubMed     Abstract available
    
    
    
72. SOHARA K, Kiriyama T, Mizumura S, Ishiwata A, et al
    Correction: Diagnostic utility and characteristics of CT-based attenuation correction in brain perfusion SPECT/CT in predicting the exacerbation of Alzheimer changes from mild cognitive impairment utilizing voxel-based statistical analysis in comparis
    Ann Nucl Med. 2023 Mar 26. doi: 10.1007/s12149-023-01831.
    PubMed    
    
    
    
73. OYA T, Ichikawa Y, Nakamura S, Tomita Y, et al
    Quantitative assessment of (99m)Tc-methylene diphosphonate bone SPECT/CT for assessing bone metastatic burden and its prognostic value in patients with castration-resistant prostate cancers: initial results in a single-center retrospective study.
    Ann Nucl Med. 2023 Mar 22. doi: 10.1007/s12149-023-01833.
    PubMed     Abstract available
    
    
    
74. JACQUET-FRANCILLON N, Prevot N
    Brown tumors in nuclear medicine: a systematic review.
    Ann Nucl Med. 2023 Mar 18. doi: 10.1007/s12149-023-01832.
    PubMed     Abstract available
    
    
    
75. MINGELS C, Weidner S, Sari H, Buesser D, et al
    Impact of the new ultra-high sensitivity mode in a long axial field-of-view PET/CT.
    Ann Nucl Med. 2023 Mar 13. doi: 10.1007/s12149-023-01827.
    PubMed     Abstract available
    
    
    
76. YAN M, Shang H, Hao L, Guo X, et al
    A preliminary study of dobutamine myocardial flow reserve on (99m)Tc-Sestamibi CZT-SPECT.
    Ann Nucl Med. 2023 Mar 9. doi: 10.1007/s12149-023-01829.
    PubMed     Abstract available
    
    
    
77. MIYAMOTO M, Okuyama C, Kagawa S, Kusano K, et al
    Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects.
    Ann Nucl Med. 2023 Mar 9. doi: 10.1007/s12149-023-01828.
    PubMed     Abstract available
    
    
    
78. SHEIKHBAHAEI S, Bello Martinez R, Markowski MC, Eisenberger MA, et al
    Multi-timepoint imaging with PSMA-targeted [(18)F]F-Florastamin PET/CT: lesion detection and comparison to conventional imaging.
    Ann Nucl Med. 2023 Mar 1. doi: 10.1007/s12149-023-01823.
    PubMed     Abstract available
    
    
    February 2023
79. JEONG YJ, Yoon HJ, Kang DY, Park KW, et al
    Quantitative comparative analysis of amyloid PET images using three radiopharmaceuticals.
    Ann Nucl Med. 2023 Feb 7. doi: 10.1007/s12149-023-01824.
    PubMed     Abstract available
    
    
    
80. YE Z, Zhang J, Wu N, Chen S, et al
    PET-guided attention for prediction of microvascular invasion in preoperative hepatocellular carcinoma on PET/CT.
    Ann Nucl Med. 2023 Feb 1. doi: 10.1007/s12149-023-01822.
    PubMed     Abstract available
    
    
    
81. CHEN YH, Chen YC, Lue KH, Chu SC, et al
    Glucose metabolic heterogeneity correlates with pathological features and improves survival stratification of resectable lung adenocarcinoma.
    Ann Nucl Med. 2023;37:139-150.
    PubMed     Abstract available
    
    
    
82. SATO T, Matsutomo N, Yamamoto T, Fukami M, et al
    Evaluation of standardized uptake value on (131)I-6beta-iodomethyl-19-norcholesterol scintigraphy for diagnosis of primary aldosteronism and correspondence with adrenal venous sampling.
    Ann Nucl Med. 2023;37:89-98.
    PubMed     Abstract available
    
    
    January 2023
83. AKAMATSU G, Tsutsui Y, Daisaki H, Mitsumoto K, et al
    A review of harmonization strategies for quantitative PET.
    Ann Nucl Med. 2023 Jan 6. doi: 10.1007/s12149-022-01820.
    PubMed     Abstract available
    
    
    
84. CHEN P, Li J, Li Z, Yu D, et al
    (18)F-FP-CIT dopamine transporter PET findings in the striatum and retina of type 1 diabetic rats.
    Ann Nucl Med. 2023 Jan 6. doi: 10.1007/s12149-022-01818.
    PubMed     Abstract available
    
    
    
85. YANG H, Gao Z, Xu X, Liu C, et al
    Dosimetry estimation and preliminary clinical application of [(99m)Tc]Tc-HYNIC-PSMA-XL-2 in prostate cancer.
    Ann Nucl Med. 2023;37:60-69.
    PubMed     Abstract available
    
    
    
86. YUAN L, Wang J, Pan L, Feng H, et al
    Outcome of patients with differentiated thyroid cancer treated with empirical radioiodine therapy on the basis of Thyroglobulin Elevation Negative Iodine Scintigraphy (TENIS) syndrome without structural disease: a retrospective cohort study.
    Ann Nucl Med. 2023;37:18-25.
    PubMed     Abstract available
    
    
    
87. FISCHER M, Zacherl MJ, Olivier J, Lindner S, et al
    Detection of apoptosis by [(18)F]ML-10 after cardiac ischemia-reperfusion injury in mice.
    Ann Nucl Med. 2023;37:34-43.
    PubMed     Abstract available
    
    
    December 2022
88. NAKAJIMA S, Fushimi Y, Hinoda T, Sakata A, et al
    Brain imaging of sequential acquisition using a flexible PET scanner and 3-T MRI: quantitative and qualitative assessment.
    Ann Nucl Med. 2022 Dec 31. doi: 10.1007/s12149-022-01817.
    PubMed     Abstract available
    
    
    
89. HOSOKAWA T, Uchiyama M, Tanami Y, Sato Y, et al
    Incidence of renal scarring on technetium-99 m dimercaptosuccinic acid renal scintigraphy after acute pyelonephritis, acute focal bacterial nephritis, and renal abscess.
    Ann Nucl Med. 2022 Dec 21. doi: 10.1007/s12149-022-01814.
    PubMed     Abstract available
    
    
    
90. SUN X, Zeng B, Tan X, Chen Z, et al
    Invasive mucinous adenocarcinoma of the lung: clinicopathological features, (18)F-FDG PET/CT findings, and survival outcomes.
    Ann Nucl Med. 2022 Dec 20. doi: 10.1007/s12149-022-01816.
    PubMed     Abstract available
    
    
    
91. WAN B, Zhang S, Wang P, Deng P, et al
    Prognostic value of semi-quantitative parameters of (18)F-FDG PET/CT in newly diagnosed multiple myeloma patients.
    Ann Nucl Med. 2022 Dec 17. doi: 10.1007/s12149-022-01812.
    PubMed     Abstract available
    
    
    
92. GRUT H, Line PD, Syversveen T, Dueland S, et al
    Metabolic tumor volume predicts long-term survival after transplantation for unresectable colorectal liver metastases: 15 years of experience from the SECA study.
    Ann Nucl Med. 2022;36:1073-1081.
    PubMed     Abstract available
    
    
    
93. SHIBUTANI T, Onoguchi M, Kanno T, Wakabayashi H, et al
    Development of a novel small-animal myocardial phantom can evaluate the image quality of dual-isotope simultaneous acquisition (DISA).
    Ann Nucl Med. 2022;36:1031-1038.
    PubMed     Abstract available
    
    
    November 2022
94. YUGE S, Miyake KK, Ishimori T, Kataoka M, et al
    Reproducibility assessment of uptake on dedicated breast PET for noise discrimination.
    Ann Nucl Med. 2022 Nov 25. doi: 10.1007/s12149-022-01809.
    PubMed     Abstract available
    
    
    
95. OHNISHI A, Akamatsu G, Ikari Y, Nishida H, et al
    Dosimetry and efficacy of a tau PET tracer [(18)F]MK-6240 in Japanese healthy elderly and patients with Alzheimer's disease.
    Ann Nucl Med. 2022 Nov 21. doi: 10.1007/s12149-022-01808.
    PubMed     Abstract available
    
    
    
96. CHO HW, Lee ES, Lee JK, Eo JS, et al
    Prognostic value of textural features obtained from F-fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) in patients with locally advanced cervical cancer undergoing concurrent chemoradiotherapy.
    Ann Nucl Med. 2022 Nov 12. pii: 10.1007/s12149-022-01802.
    PubMed     Abstract available
    
    
    
97. SAITOU T, Aikawa T, Manabe O, Nagase A, et al
    Comparison of 1-h with 3-h planar (99m)Tc-pyrophosphate scintigraphy in patients with suspected transthyretin cardiac amyloidosis using SPECT as a reference standard.
    Ann Nucl Med. 2022 Nov 10. pii: 10.1007/s12149-022-01807.
    PubMed     Abstract available
    
    
    
98. CHEN Z, Nakajima K, Hirano KI, Kamiya T, et al
    Methods of calculating (123)I-beta-methyl-P-iodophenyl-pentadecanoic acid washout rates in triglyceride deposit cardiomyovasculopathy.
    Ann Nucl Med. 2022;36:986-997.
    PubMed     Abstract available
    
    
    
99. KAIHANI S, Sadeghzadeh N, Abediankenari S, Abedi SM, et al
    [(99m)Tc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a alphavbeta3-positive tumor.
    Ann Nucl Med. 2022;36:976-985.
    PubMed     Abstract available
    
    
    October 2022
100. LINGUANTI F, Abenavoli EM, Briganti V, Danti G, et al
     Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study.
     Ann Nucl Med. 2022 Oct 30. pii: 10.1007/s12149-022-01797.
     PubMed     Abstract available
     
     
     
101. WENG S, Li Y, Wang Q, Zhao Y, et al
     Differentiation of lower limb vasculitis from physiological uptake on FDG PET/CT imaging.
     Ann Nucl Med. 2022 Oct 28. pii: 10.1007/s12149-022-01800.
     PubMed     Abstract available
     
     
     
102. TAKENAKA J, Watanabe S, Abe T, Hirata K, et al
     Prognostic value of [(18)F]FDG-PET prior to [(131)I]MIBG treatment for pheochromocytoma and paraganglioma (PPGL).
     Ann Nucl Med. 2022 Oct 27. pii: 10.1007/s12149-022-01798.
     PubMed     Abstract available
     
     
     
103. KAJIYAMA A, Ito K, Watanabe H, Mizumura S, et al
     Consistency and prognostic value of preoperative staging and postoperative pathological staging using (18)F-FDG PET/MRI in patients with non-small cell lung cancer.
     Ann Nucl Med. 2022 Oct 20. pii: 10.1007/s12149-022-01795.
     PubMed     Abstract available
     
     
     
104. SATOH Y, Imai M, Ikegawa C, Hirata K, et al
     Effect of radioactivity outside the field of view on image quality of dedicated breast positron emission tomography: preliminary phantom and clinical studies.
     Ann Nucl Med. 2022 Oct 8. pii: 10.1007/s12149-022-01789.
     PubMed     Abstract available
     
     
     
105. MATSUDA H, Okita K, Motoi Y, Mizuno T, et al
     Clinical impact of amyloid PET using (18)F-florbetapir in patients with cognitive impairment and suspected Alzheimer's disease: a multicenter study.
     Ann Nucl Med. 2022 Oct 4. pii: 10.1007/s12149-022-01792.
     PubMed     Abstract available
     
     
     
106. TSUKADA H, Tsukada J, Ochi T, Noguchi E, et al
     Radiological predictive factors on preoperative multimodality imaging are related to Oncotype DX recurrence score in estrogen-positive/human epidermal growth factor receptor 2-negative invasive breast cancer: a cross-sectional study.
     Ann Nucl Med. 2022;36:853-864.
     PubMed     Abstract available
     
     
     September 2022
107. LIU J, Yu J, Liu HB, Yao Q, et al
     Chronic fluoxetine enhances extinction therapy for PTSD by evaluating brain glucose metabolism in rats: an [(18)F]FDG PET study.
     Ann Nucl Med. 2022 Sep 30. pii: 10.1007/s12149-022-01790.
     PubMed     Abstract available
     
     
     
108. MIZUTA T, Yamakawa Y, Minagawa S, Kobayashi T, et al
     Attenuation correction for phantom tests: an alternative to maximum-likelihood attenuation correction factor-based correction for clinical studies in time-of-flight PET.
     Ann Nucl Med. 2022 Sep 28. pii: 10.1007/s12149-022-01788.
     PubMed     Abstract available
     
     
     
109. WATANABE M, Kato H, Katayama D, Soeda F, et al
     Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose-positron emission tomography to differentiate between benign and malignant lesions.
     Ann Nucl Med. 2022 Sep 3. pii: 10.1007/s12149-022-01784.
     PubMed     Abstract available
     
     
     
110. ICHIKAWA H, Shibutani T, Onoguchi M, Taniguchi Y, et al
     New index to assess the extent of bone disease in patients with prostate cancer using SPECT/CT.
     Ann Nucl Med. 2022 Sep 1. pii: 10.1007/s12149-022-01783.
     PubMed     Abstract available
     
     
     August 2022
111. TELLI TA, Ozguven S, Alan O, Filizoglu N, et al
     Role of baseline (68)Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment.
     Ann Nucl Med. 2022 Aug 23. pii: 10.1007/s12149-022-01785.
     PubMed     Abstract available
     
     
     
112. NAKAJIMA K, Saito S, Chen Z, Komatsu J, et al
     Diagnosis of Parkinson syndrome and Lewy-body disease using (123)I-ioflupane images and a model with image features based on machine learning.
     Ann Nucl Med. 2022;36:765-776.
     PubMed     Abstract available
     
     
     
113. UKON N, Higashi T, Hosono M, Kinuya S, et al
     Manual on the proper use of meta-[(211)At] astato-benzylguanidine ([(211)At] MABG) injections in clinical trials for targeted alpha therapy (1st edition).
     Ann Nucl Med. 2022;36:695-709.
     PubMed     Abstract available
     
     
     
114. SAKURAI K, Nihashi T, Kimura Y, Iwata K, et al
     Age-related increase of monoamine oxidase B in amyloid-negative cognitively unimpaired elderly subjects.
     Ann Nucl Med. 2022;36:777-784.
     PubMed     Abstract available
     
     
     
115. KOMORI S, Cross DJ, Mills M, Ouchi Y, et al
     Deep-learning prediction of amyloid deposition from early-phase amyloid positron emission tomography imaging.
     Ann Nucl Med. 2022 Aug 1. pii: 10.1007/s12149-022-01775.
     PubMed     Abstract available
     
     
     July 2022
116. NAKAMOTO Y, Kitajima K, Toriihara A, Nakajo M, et al
     Recent topics of the clinical utility of PET/MRI in oncology and neuroscience.
     Ann Nucl Med. 2022 Jul 27. pii: 10.1007/s12149-022-01780.
     PubMed     Abstract available
     
     
     
117. LV J, Yin H, Yu H, Liu G, et al
     The feasibility of ultralow-activity (18)F-FDG dynamic PET imaging in lung adenocarcinoma patients through total-body PET/CT scanner.
     Ann Nucl Med. 2022 Jul 20. pii: 10.1007/s12149-022-01772.
     PubMed     Abstract available
     
     
     
118. IWAO Y, Akamatsu G, Tashima H, Takahashi M, et al
     Brain PET motion correction using 3D face-shape model: the first clinical study.
     Ann Nucl Med. 2022 Jul 19. pii: 10.1007/s12149-022-01774.
     PubMed     Abstract available
     
     
     
119. GIHBID A, Cherkaoui Salhi G, El Alami I, Belgadir H, et al
     Pretreatment [(18)F]FDG PET/CT and MRI in the prognosis of nasopharyngeal carcinoma.
     Ann Nucl Med. 2022 Jul 14. pii: 10.1007/s12149-022-01770.
     PubMed     Abstract available
     
     
     
120. YANG W, Zhong Z, Feng G, Wang Z, et al
     Advances in positron emission tomography tracers related to vascular calcification.
     Ann Nucl Med. 2022 Jul 14. pii: 10.1007/s12149-022-01771.
     PubMed     Abstract available
     
     
     
121. NISHIMORI M, Iwasa H, Miyatake K, Nitta N, et al
     18F FDG-PET/CT analysis of spread through air spaces (STAS) in clinical stage I lung adenocarcinoma.
     Ann Nucl Med. 2022 Jul 12. pii: 10.1007/s12149-022-01773.
     PubMed     Abstract available
     
     
     
122. IMABAYASHI E, Tamamura N, Yamaguchi Y, Kamitaka Y, et al
     Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.
     Ann Nucl Med. 2022 Jul 11. pii: 10.1007/s12149-022-01769.
     PubMed     Abstract available
     
     
     
123. CUI B, Shan Y, Zhang T, Ma Y, et al
     Crossed cerebellar diaschisis-related supratentorial hemodynamic and metabolic status measured by PET/MR in assessing postoperative prognosis in chronic ischemic cerebrovascular disease patients with bypass surgery.
     Ann Nucl Med. 2022 Jul 5. pii: 10.1007/s12149-022-01766.
     PubMed     Abstract available
     
     
     
124. KUNITA Y, Nakajima K, Nakata T, Kudo T, et al
     Prediction of multivessel coronary artery disease and candidates for stress-only imaging using multivariable models with myocardial perfusion imaging.
     Ann Nucl Med. 2022;36:674-683.
     PubMed     Abstract available
     
     
     
125. NDLOVU H, Lawal IO, Popoola GO, Brits B, et al
     [(68)Ga]Ga-NODAGAZOL uptake in atherosclerotic plaques correlates with the cardiovascular risk profile of patients.
     Ann Nucl Med. 2022;36:684-692.
     PubMed     Abstract available
     
     
     
126. YILMAZ B, Sahin S, Ergul N, Colakoglu Y, et al
     (99m)Tc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients.
     Ann Nucl Med. 2022;36:597-609.
     PubMed     Abstract available
     
     
     June 2022
127. PAPANDRIANOS NI, Apostolopoulos ID, Feleki A, Apostolopoulos DJ, et al
     Deep learning exploration for SPECT MPI polar map images classification in coronary artery disease.
     Ann Nucl Med. 2022 Jun 30. pii: 10.1007/s12149-022-01762.
     PubMed     Abstract available
     
     
     
128. FARKAS B, Kepes Z, Barna SK, Szugyiczki V, et al
     Unusual perfusion patterns on perfusion-only SPECT/CT scans in COVID-19 patients.
     Ann Nucl Med. 2022 Jun 28. pii: 10.1007/s12149-022-01761.
     PubMed     Abstract available
     
     
     
129. LI J, Huang L, Luo Y, Zhang K, et al
     Inferences of SPECT renal dynamic imaging injection quality based on lung and abdominal aorta imaging features.
     Ann Nucl Med. 2022 Jun 22. pii: 10.1007/s12149-022-01750.
     PubMed     Abstract available
     
     
     
130. DE JONG TL, Koopman D, van Dalen JA, Tegelaar A, et al
     Performance of digital PET/CT compared with conventional PET/CT in oncologic patients: a prospective comparison study.
     Ann Nucl Med. 2022 Jun 21. pii: 10.1007/s12149-022-01758.
     PubMed     Abstract available
     
     
     
131. ONISHI Y, Isobe T, Ito M, Hashimoto F, et al
     Performance evaluation of dedicated brain PET scanner with motion correction system.
     Ann Nucl Med. 2022 Jun 13. pii: 10.1007/s12149-022-01757.
     PubMed     Abstract available
     
     
     
132. XU J, Li Y, Xie L, Sun X, et al
     An evaluation of the response to neoadjuvant chemotherapy for osteosarcoma of extremities: PERCIST versus RECIST 1.1 criteria after long-term follow-up.
     Ann Nucl Med. 2022;36:553-561.
     PubMed     Abstract available
     
     
     May 2022
133. APRIL G, De Bruycker JJ, Decaluwe H, Haddad E, et al
     Evaluation of physiological Waldeyer's ring, mediastinal blood pool, thymic, bone marrow, splenic and hepatic activity with (18)F-FDG PET/CT: exploration of normal range among pediatric patients.
     Ann Nucl Med. 2022 May 29. pii: 10.1007/s12149-022-01748.
     PubMed     Abstract available
     
     
     
134. TOMITA Y, Ichikawa Y, Sakuma H
     Shine-through artifact due to high-radioactivity bladder and bowel gas in (18)F-FDG PET/CT: impact of time-of-flight algorithm and radioactivity concentration of urine in the bladder on the occurrence of the artifacts.
     Ann Nucl Med. 2022 May 28. pii: 10.1007/s12149-022-01756.
     PubMed     Abstract available
     
     
     
135. IBARAKI M, Matsubara K, Shinohara Y, Shidahara M, et al
     Brain partial volume correction with point spreading function reconstruction in high-resolution digital PET: comparison with an MR-based method in FDG imaging.
     Ann Nucl Med. 2022 May 26. pii: 10.1007/s12149-022-01753.
     PubMed     Abstract available
     
     
     
136. SHIMIZU Y, Satake H, Ishigaki S, Shimamoto K, et al
     Physiological background parenchymal uptake of (18)F-FDG in normal breast tissues using dedicated breast PET: correlation with mammographic breast composition, menopausal status, and menstrual cycle.
     Ann Nucl Med. 2022 May 24. pii: 10.1007/s12149-022-01754.
     PubMed     Abstract available
     
     
     
137. BAI Z, Zhou T, Yu Z, Chen Y, et al
     Clinical value of (18)F-FDG PET/CT in IgG4-related disease.
     Ann Nucl Med. 2022 May 23. pii: 10.1007/s12149-022-01749.
     PubMed     Abstract available
     
     
     
138. CHEN Y, Zheng S, Zhang J, Yao S, et al
     (68)Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients.
     Ann Nucl Med. 2022 May 12. pii: 10.1007/s12149-022-01742.
     PubMed     Abstract available
     
     
     
139. FUKAI S, Daisaki H, Umeda T, Shimada N, et al
     Impact of patient body habitus on image quality and quantitative value in bone SPECT/CT.
     Ann Nucl Med. 2022 May 11. pii: 10.1007/s12149-022-01746.
     PubMed     Abstract available
     
     
     
140. TAN X, Li D, Wu X, Yang Y, et al
     Physiologically intense FDG uptake of distal spinal cord on total-body PET/CT.
     Ann Nucl Med. 2022 May 10. pii: 10.1007/s12149-022-01747.
     PubMed     Abstract available
     
     
     
141. BECK M, Hartwich J, Eckstein M, Schmidt D, et al
     F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial.
     Ann Nucl Med. 2022 May 10. pii: 10.1007/s12149-022-01744.
     PubMed     Abstract available
     
     
     
142. TALEBI AS, Rajabi H, Watabe H
     Role of nanoparticles in transarterial radioembolization with glass microspheres.
     Ann Nucl Med. 2022;36:479-487.
     PubMed     Abstract available
     
     
     
143. YOSHIDA A, Ueda D, Higashiyama S, Katayama Y, et al
     Deep learning-based detection of parathyroid adenoma by (99m)Tc-MIBI scintigraphy in patients with primary hyperparathyroidism.
     Ann Nucl Med. 2022;36:468-478.
     PubMed     Abstract available
     
     
     
144. SHIGEMOTO Y, Matsuda H, Kimura Y, Chiba E, et al
     Voxel-based analysis of age and gender effects on striatal [(123)I] FP-CIT binding in healthy Japanese adults.
     Ann Nucl Med. 2022;36:460-467.
     PubMed     Abstract available
     
     
     April 2022
145. YAMA N, Nagoya S, Sugita S, Koyama M, et al
     Diagnosis of prosthetic joint infection at the hip using the standard uptake value of three-phase 99mTc-hydroxymethylene diphosphonate SPECT/CT.
     Ann Nucl Med. 2022 Apr 28. pii: 10.1007/s12149-022-01745.
     PubMed     Abstract available
     
     
     
146. ERDOGAN M, Sengul SS, Cetin B, Avci M, et al
     The role of Ga(68) PSMA PET/CT imaging in Lu(177) PSMA treatment planning in metastatic castration-resistant prostate cancer.
     Ann Nucl Med. 2022 Apr 9. pii: 10.1007/s12149-022-01739.
     PubMed     Abstract available
     
     
     
147. KIM D, Lee WJ, Lee HW, Kim BS, et al
     Application of (18)F-FDG brain PET for survival prediction in a rat model of hanging-induced hypoxic brain injury.
     Ann Nucl Med. 2022 Apr 5. pii: 10.1007/s12149-022-01738.
     PubMed     Abstract available
     
     
     
148. OKUDA K, Saito H, Yamashita S, Yamamoto H, et al
     Beads phantom for evaluating heterogeneity of SUV on (18)F-FDG PET images.
     Ann Nucl Med. 2022 Apr 4. pii: 10.1007/s12149-022-01740.
     PubMed     Abstract available
     
     
     
149. ZOU S, Song S, Zhou J, Yu B, et al
     Time point-independent tumor positivity of (68)Ga-PSMA-PET/CT pre- and post-biopsy in high-risk prostate cancer.
     Ann Nucl Med. 2022 Apr 1. pii: 10.1007/s12149-022-01732.
     PubMed     Abstract available
     
     
     
150. KUBOTA K, Saginoya T, Ishiwata K, Nakasato T, et al
     [(18)F]FDG uptake in axillary lymph nodes and deltoid muscle after COVID-19 mRNA vaccination: a cohort study to determine incidence and contributing factors using a multivariate analysis.
     Ann Nucl Med. 2022;36:340-350.
     PubMed     Abstract available
     
     
     
151. NAKATA T, Shimada K, Iba A, Oda H, et al
     Correlation between noise pareidolia test scores for visual hallucinations and regional cerebral blood flow in dementia with Lewy bodies.
     Ann Nucl Med. 2022;36:384-392.
     PubMed     Abstract available
     
     
     
152. BAUCKNEHT M, Lai R, D'Amico F, Miceli A, et al
     Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223.
     Ann Nucl Med. 2022;36:373-383.
     PubMed     Abstract available
     
     
     
153. KIDERA E, Koyasu S, Hayakawa N, Ishimori T, et al
     Association between diffuse renal uptake of (18)F-FDG and acute kidney injury.
     Ann Nucl Med. 2022;36:351-359.
     PubMed     Abstract available
     
     
     March 2022
154. FISCHER M, Weinberger T, Messerer D, Zacherl MJ, et al
     Comparison of transient and permanent LAD ligation in mice using 18F-FDG PET imaging.
     Ann Nucl Med. 2022 Mar 30. pii: 10.1007/s12149-022-01734.
     PubMed     Abstract available
     
     
     
155. SUZUKI M, Izawa Y, Fujita H, Miwa K, et al
     Efficacy of myocardial washout of (99m)Tc-MIBI/Tetrofosmin for the evaluation of inflammation in patients with cardiac sarcoidosis: comparison with (18)F-fluorodeoxyglucose positron emission tomography findings.
     Ann Nucl Med. 2022 Mar 18. pii: 10.1007/s12149-022-01735.
     PubMed     Abstract available
     
     
     
156. OTANI T, Saga T, Ishimori T, Kidera E, et al
     Correction to: Detection efficacy of PET/CT with (18)F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study.
     Ann Nucl Med. 2022 Mar 17. pii: 10.1007/s12149-022-01736.
     PubMed    
     
     
     
157. KRENGLI M, Ferrara E, Guaschino R, Puta E, et al
     18F-FDG PET/CT as predictive and prognostic factor in esophageal cancer treated with combined modality treatment.
     Ann Nucl Med. 2022 Mar 11. pii: 10.1007/s12149-022-01733.
     PubMed     Abstract available
     
     
     
158. EUDE F, Guisier F, Salaun M, Thiberville L, et al
     Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumab.
     Ann Nucl Med. 2022;36:224-234.
     PubMed     Abstract available
     
     
     
159. MIYAZAKI Y, Kameyama M, Nakamizo A, Noguchi T, et al
     Validity of the gamma-Ray Evaluation with iodoamphetamine for Cerebral Blood Flow Assessment (REICA) method for quantification of cerebral blood flow including acetazolamide challenge test.
     Ann Nucl Med. 2022;36:279-284.
     PubMed     Abstract available
     
     
     
160. TAKAHASHI M, Yoshimura S, Takyu S, Aikou S, et al
     A design of forceps-type coincidence radiation detector for intraoperative LN diagnosis: clinical impact estimated from LNs data of 20 esophageal cancer patients.
     Ann Nucl Med. 2022;36:285-292.
     PubMed     Abstract available
     
     
     
161. MORISHIMA M, Kiriyama T, Miyagi Y, Otsuka T, et al
     Serial change in perfusion-metabolism mismatch after coronary artery bypass grafting.
     Ann Nucl Med. 2022;36:244-254.
     PubMed     Abstract available
     
     
     
162. LUE KH, Chu SC, Wang LY, Chen YC, et al
     Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma.
     Ann Nucl Med. 2022;36:256-266.
     PubMed     Abstract available
     
     
     February 2022
163. AHMED N, Sadeq A, Marafi F, Gnanasegaran G, et al
     Therapy-induced bone changes in oncology imaging with (18)F-sodium fluoride (NaF) PET-CT.
     Ann Nucl Med. 2022 Feb 26. pii: 10.1007/s12149-022-01730.
     PubMed     Abstract available
     
     
     
164. NESTEROV SV, Deshayes E, Juarez-Orozco LE, deKemp RA, et al
     Myocardial perfusion quantification with Rb-82 PET: good interobserver agreement of Carimas software on global, regional, and segmental levels.
     Ann Nucl Med. 2022 Feb 22. pii: 10.1007/s12149-022-01729.
     PubMed     Abstract available
     
     
     
165. WANG L, Han X, Wang M, Ma X, et al
     Ventilation/perfusion imaging predicts response to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
     Ann Nucl Med. 2022 Feb 22. pii: 10.1007/s12149-022-01731.
     PubMed     Abstract available
     
     
     
166. CHO SG, Kim YH, Park H, Park KS, et al
     Prediction of cardiac events following concurrent chemoradiation therapy for non-small-cell lung cancer using FDG PET.
     Ann Nucl Med. 2022 Feb 17. pii: 10.1007/s12149-022-01724.
     PubMed     Abstract available
     
     
     
167. MIZUTA T, Kobayashi T, Yamakawa Y, Hanaoka K, et al
     Initial evaluation of a new maximum-likelihood attenuation correction factor-based attenuation correction for time-of-flight brain PET.
     Ann Nucl Med. 2022 Feb 9. pii: 10.1007/s12149-022-01721.
     PubMed     Abstract available
     
     
     
168. ZHAO L, Wang H, Shi J
     (18)F-FDG PET/CT characteristics of solitary fibrous tumour of the pleura: single institution experience.
     Ann Nucl Med. 2022 Feb 8. pii: 10.1007/s12149-022-01723.
     PubMed     Abstract available
     
     
     
169. PLYKU D, Hobbs RF, Wu D, Garcia C, et al
     I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response.
     Ann Nucl Med. 2022 Feb 4. pii: 10.1007/s12149-021-01655.
     PubMed     Abstract available
     
     
     
170. NAGAHATA K, Kanda M, Kamekura R, Sugawara M, et al
     Abnormal [(18)F]fluorodeoxyglucose accumulation to tori tubarius in IgG4-related disease.
     Ann Nucl Med. 2022;36:200-207.
     PubMed     Abstract available
     
     
     January 2022
171. THAWEERAT W
     Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy.
     Ann Nucl Med. 2022 Jan 30. pii: 10.1007/s12149-021-01712.
     PubMed    
     
     
     
172. SATOH Y, Imokawa T, Fujioka T, Mori M, et al
     Deep learning for image classification in dedicated breast positron emission tomography (dbPET).
     Ann Nucl Med. 2022 Jan 27. pii: 10.1007/s12149-022-01719.
     PubMed     Abstract available
     
     
     
173. SHI A, Wang J, Wang Y, Guo G, et al
     Predictive value of multiple metabolic and heterogeneity parameters of (18)F-FDG PET/CT for EGFR mutations in non-small cell lung cancer.
     Ann Nucl Med. 2022 Jan 27. pii: 10.1007/s12149-022-01718.
     PubMed     Abstract available
     
     
     
174. INOUE Y, Ohkubo Y, Nagahara K, Uehara A, et al
     Conversion from dose length product to effective dose for the CT component of whole-body PET/CT.
     Ann Nucl Med. 2022 Jan 24. pii: 10.1007/s12149-022-01720.
     PubMed     Abstract available
     
     
     
175. OTANI T, Saga T, Ishimori T, Kidera E, et al
     Detection efficacy of PET/CT with (18)F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study.
     Ann Nucl Med. 2022 Jan 22. pii: 10.1007/s12149-021-01704.
     PubMed     Abstract available
     
     
     
176. MATSUBARA K, Ibaraki M, Nemoto M, Watabe H, et al
     A review on AI in PET imaging.
     Ann Nucl Med. 2022 Jan 14. pii: 10.1007/s12149-021-01710.
     PubMed     Abstract available
     
     
     
177. AKAMATSU G, Shimada N, Matsumoto K, Daisaki H, et al
     New standards for phantom image quality and SUV harmonization range for multicenter oncology PET studies.
     Ann Nucl Med. 2022 Jan 14. pii: 10.1007/s12149-021-01709.
     PubMed     Abstract available
     
     
     
178. MCKAY MJ, Taubman KL, Lee S, Scott AM, et al
     Radiotherapy planning of lymphomas: role of metabolic imaging with PET/CT.
     Ann Nucl Med. 2022 Jan 14. pii: 10.1007/s12149-021-01703.
     PubMed     Abstract available
     
     
     
179. HIRATA K, Sugimori H, Fujima N, Toyonaga T, et al
     Artificial intelligence for nuclear medicine in oncology.
     Ann Nucl Med. 2022 Jan 14. pii: 10.1007/s12149-021-01693.
     PubMed     Abstract available
     
     
     
180. WATANABE S, Ueno T, Kimura Y, Mishina M, et al
     Correction to: Generative image transformer (GIT): unsupervised continuous image generative and transformable model for [(123)I]FP-CIT SPECT images.
     Ann Nucl Med. 2022 Jan 6. pii: 10.1007/s12149-021-01714.
     PubMed    
     
     
     
181. AKSU A, Vural Topuz O, Yilmaz G, Capa Kaya G, et al
     Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses.
     Ann Nucl Med. 2022 Jan 6. pii: 10.1007/s12149-021-01705.
     PubMed     Abstract available
     
     
     December 2021
182. KESSEL K, Seifert R, Weckesser M, Boegemann M, et al
     Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging.
     Ann Nucl Med. 2021 Dec 2. pii: 10.1007/s12149-021-01702.
     PubMed     Abstract available
     
     
     
183. HASHIMOTO T, Kondo N, Hirata M, Temma T, et al
     Development of radioiodinated pyrimidinopyridone derivatives as targeted imaging probes of activated p38alpha for single photon emission computed tomography.
     Ann Nucl Med. 2021;35:1293-1304.
     PubMed     Abstract available
     
     
     November 2021
184. KITAMURA Y, Baba S, Isoda T, Maruoka Y, et al
     Usefulness of semi-quantitative analysis in (123)I metaiodobenzylguanidine SPECT/CT for the differentiation of pheochromocytoma and cortical adenoma.
     Ann Nucl Med. 2021 Nov 26. pii: 10.1007/s12149-021-01690.
     PubMed     Abstract available
     
     
     
185. MA X, Guo L, Zhang H, Han K, et al
     Predictive value of SPECT myocardial perfusion imaging in patients with unrevascularized coronary chronic total occlusion.
     Ann Nucl Med. 2021 Nov 10. pii: 10.1007/s12149-021-01692.
     PubMed     Abstract available
     
     
     
186. ICHIKAWA H, Miyaji N, Onoguchi M, Shibutani T, et al
     Feasibility of ultra-high-speed acquisition in xSPECT bone algorithm: a phantom study with advanced bone SPECT-specific phantom.
     Ann Nucl Med. 2021 Nov 3. pii: 10.1007/s12149-021-01689.
     PubMed     Abstract available
     
     
     
187. GUO H, Xu K, Duan G, Wen L, et al
     Progress and future prospective of FDG-PET/CT imaging combined with optimized procedures in lung cancer: toward precision medicine.
     Ann Nucl Med. 2021 Nov 2. pii: 10.1007/s12149-021-01683.
     PubMed     Abstract available
     
     
     
188. ADVANI P, Chumsri S, Pai T, Li Z, et al
     Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients.
     Ann Nucl Med. 2021;35:1264-1269.
     PubMed     Abstract available
     
     
     October 2021
189. CHEN Y, Wang Z, Yin G, Sui C, et al
     Prediction of HER2 expression in breast cancer by combining PET/CT radiomic analysis and machine learning.
     Ann Nucl Med. 2021 Oct 30. pii: 10.1007/s12149-021-01688.
     PubMed     Abstract available
     
     
     
190. OZKAN ZG, Has Simsek D, Kuyumcu S, Oflas M, et al
     Prognostic value of FDG PET-CT in suspected recurrence of colorectal carcinoma: survival outcomes of a 10-year follow-up : FDG PET in recurrent colorectal CA.
     Ann Nucl Med. 2021 Oct 14. pii: 10.1007/s12149-021-01684.
     PubMed     Abstract available
     
     
     
191. KAWAKUBO M, Nagao M, Kikuchi N, Yamamoto A, et al
     (13)N-ammonia positron emission tomography-derived left-ventricular strain in patients after heart transplantation validated using cardiovascular magnetic resonance feature tracking as reference.
     Ann Nucl Med. 2021 Oct 13. pii: 10.1007/s12149-021-01686.
     PubMed     Abstract available
     
     
     
192. NAKAYA M, Kurokawa R, Kanemaru N, Sakamoto N, et al
     Physiological 2-deoxy-2-[fluorine-18] fluoro-D-glucose accumulation in the thenar eminence in adults: a single-center retrospective study.
     Ann Nucl Med. 2021;35:1167-1173.
     PubMed     Abstract available
     
     
     
193. TARTAGLIONE G, Foschi N, Ragonese M, Recupero SM, et al
     A gravity-assisted approach to the management of urinary diversion: (99m)Tc-MAG3 diuresis renography with F + 10(sp) method.
     Ann Nucl Med. 2021;35:1127-1135.
     PubMed     Abstract available
     
     
     September 2021
194. ONWANNA J, Chantadisai M, Tepmongkol S, Fahey F, et al
     Impact of reconstruction parameters on lesion detection and localization in joint ictal/inter-ictal SPECT reconstruction.
     Ann Nucl Med. 2021 Sep 24. pii: 10.1007/s12149-021-01680.
     PubMed     Abstract available
     
     
     
195. IONESCU TM, Jalloul W, Stolniceanu CR, Iacob R, et al
     Transthyretin cardiac amyloidosis: a review of the nuclear imaging findings with emphasis on the radiotracers mechanisms.
     Ann Nucl Med. 2021;35:967-993.
     PubMed     Abstract available
     
     
     August 2021
196. ELBOGA U, Sahin E, Kus T, Cayirli YB, et al
     Superiority of (68)Ga-FAPI PET/CT scan in detecting additional lesions compared to (18)FDG PET/CT scan in breast cancer.
     Ann Nucl Med. 2021 Aug 26. pii: 10.1007/s12149-021-01672.
     PubMed     Abstract available
     
     
     
197. KOTANI T, Nishimura M, Tamaki N, Matsushima S, et al
     Comparison between dynamic whole-body FDG-PET and early-delayed imaging for the assessment of motion in focal uptake in colorectal area.
     Ann Nucl Med. 2021 Aug 23. pii: 10.1007/s12149-021-01671.
     PubMed     Abstract available
     
     
     
198. ZHENG S, Lin R, Chen S, Zheng J, et al
     Characterization of the benign lesions with increased (68)Ga-FAPI-04 uptake in PET/CT.
     Ann Nucl Med. 2021 Aug 23. pii: 10.1007/s12149-021-01673.
     PubMed     Abstract available
     
     
     
199. WAKABAYASHI T, Hirose Y, Miyake K, Arakawa Y, et al
     Determining the extent of tumor resection at surgical planning with (18)F-fluciclovine PET/CT in patients with suspected glioma: multicenter phase III trials.
     Ann Nucl Med. 2021 Aug 18. pii: 10.1007/s12149-021-01670.
     PubMed     Abstract available
     
     
     
200. UCHIYAMA Y, Hirata K, Watanabe S, Okamoto S, et al
     Development and validation of a prediction model based on the organ-based metabolic tumor volume on FDG-PET in patients with differentiated thyroid carcinoma.
     Ann Nucl Med. 2021 Aug 11. pii: 10.1007/s12149-021-01664.
     PubMed     Abstract available
     
     
     
201. KITA A, Okazawa H, Sugimoto K, Kaido R, et al
     Acquisition count dependence of the specific binding ratio in (123)I-FP-CIT SPECT.
     Ann Nucl Med. 2021 Aug 10. pii: 10.1007/s12149-021-01668.
     PubMed     Abstract available
     
     
     
202. ITO K, Kitajima K, Toriihara A, Ishibashi M, et al
     (18)F-FDG PET/CT for monitoring anti-PD-1 therapy in patients with non-small cell lung cancer using SUV harmonization of results obtained with various types of PET/CT scanners used at different centers.
     Ann Nucl Med. 2021 Aug 9. pii: 10.1007/s12149-021-01667.
     PubMed     Abstract available
     
     
     
203. TOYOHARA J, Sakata M, Ishibashi K, Mossel P, et al
     First clinical assessment of [(18)F]MC225, a novel fluorine-18 labelled PET tracer for measuring functional P-glycoprotein at the blood-brain barrier.
     Ann Nucl Med. 2021 Aug 8. pii: 10.1007/s12149-021-01666.
     PubMed     Abstract available
     
     
     
204. WATANABE S, Ueno T, Kimura Y, Mishina M, et al
     Generative image transformer (GIT): unsupervised continuous image generative and transformable model for [(123)I]FP-CIT SPECT images.
     Ann Nucl Med. 2021 Aug 4. pii: 10.1007/s12149-021-01661.
     PubMed     Abstract available
     
     
     July 2021
205. BORGHETTI P, Toraci C, Imbrescia J, Volpi G, et al
     The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy.
     Ann Nucl Med. 2021 Jul 28. pii: 10.1007/s12149-021-01662.
     PubMed    
     
     
     
206. JO KH, Kim S, Hwang SH, Jeong YH, et al
     Characteristics of surgically transposed ovaries on (18)F-FDG PET/CT among patients with cancer.
     Ann Nucl Med. 2021 Jul 26. pii: 10.1007/s12149-021-01645.
     PubMed     Abstract available
     
     
     
207. ACUNA HERNANDEZ M, Sanchez Orduz L, Cancino Ramos U, Vallejo Armenta P, et al
     Is there a consensus between clinical practice guidelines for conventional and molecular nuclear medicine studies in parathyroid pathology?
     Ann Nucl Med. 2021 Jul 24. pii: 10.1007/s12149-021-01658.
     PubMed     Abstract available
     
     
     
208. SAGARA H, Inoue K, Yaku H, Ohsawa A, et al
     Optimization of injection dose in (18)F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan.
     Ann Nucl Med. 2021 Jul 21. pii: 10.1007/s12149-021-01656.
     PubMed     Abstract available
     
     
     
209. GALIUTO L, Leccisotti L, Locorotondo G, Porto I, et al
     Coronary plaque instability assessed by positron emission tomography and optical coherence tomography.
     Ann Nucl Med. 2021 Jul 17. pii: 10.1007/s12149-021-01651.
     PubMed     Abstract available
     
     
     
210. GREGG S, Keramida G, Peters AM
     Measuring myocardial blood flow with (82)rubidium using Gjedde-Patlak-Rutland graphical analysis.
     Ann Nucl Med. 2021;35:777-784.
     PubMed     Abstract available
     
     
     
211. SEKIKAWA Y, Funada K, Akamatsu G, Himuro K, et al
     Monte Carlo simulation of the acquisition conditions for (177)Lu molecular imaging of hepatic tumors.
     Ann Nucl Med. 2021;35:823-833.
     PubMed     Abstract available
     
     
     
212. MORLAND D, Zizi G, Godard F, Gauchy AC, et al
     18F-FDG cerebellum/liver index as a prognostic factor for progression-free survival in diffuse large B-cell lymphoma.
     Ann Nucl Med. 2021;35:785-793.
     PubMed     Abstract available
     
     
     
213. KOBAYASHI Y, Okui T, Tsujimoto M, Ikeda H, et al
     Effect of morphological findings in computed tomography on the quantitative values in single-photon emission computed tomography for patients with antiresorptive agent-related osteonecrosis of the jaw: a cross-sectional study.
     Ann Nucl Med. 2021;35:853-860.
     PubMed     Abstract available
     
     
     
214. WATABE T, Hosono M, Kinuya S, Yamada T, et al
     Manual on the proper use of sodium astatide ([(211)At]NaAt) injections in clinical trials for targeted alpha therapy (1st edition).
     Ann Nucl Med. 2021;35:753-766.
     PubMed     Abstract available
     
     
     
215. MA G, Gu B, Hu J, Kong L, et al
     Pretreatment (18)F-FDG uptake heterogeneity can predict treatment outcome of carbon ion radiotherapy in patients with locally recurrent nasopharyngeal carcinoma.
     Ann Nucl Med. 2021;35:834-842.
     PubMed     Abstract available
     
     
     June 2021
216. KUYUMCU S, Isik EG, Tiryaki TO, Has-Simsek D, et al
     Prognostic significance of (68)Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to (18)F-FDG PET/CT and laboratory results.
     Ann Nucl Med. 2021 Jun 29. pii: 10.1007/s12149-021-01652.
     PubMed     Abstract available
     
     
     
217. FASSBIND S, Ferraro DA, Stelmes JJ, Fankhauser CD, et al
     (68)Ga-PSMA-11 PET imaging in patients with ongoing androgen deprivation therapy for advanced prostate cancer.
     Ann Nucl Med. 2021 Jun 29. pii: 10.1007/s12149-021-01646.
     PubMed     Abstract available
     
     
     
218. OZTURK BC, Atahan E, Gencer A, Harbiyeli DO, et al
     Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism.
     Ann Nucl Med. 2021 Jun 25. pii: 10.1007/s12149-021-01647.
     PubMed     Abstract available
     
     
     
219. KARLS S, Gold R, Kravets S, Wang Y, et al
     Correlation of 68Ga-DOTATATE uptake on PET/CT with pathologic features of cellular proliferation in neuroendocrine neoplasms.
     Ann Nucl Med. 2021 Jun 19. pii: 10.1007/s12149-021-01642.
     PubMed     Abstract available
     
     
     
220. KAUSHIK P, Patel C, Gulati GS, Seth S, et al
     Comparison of (68)Ga-DOTANOC PET/CT with cardiac MRI in patients with clinical suspicion of cardiac sarcoidosis.
     Ann Nucl Med. 2021 Jun 14. pii: 10.1007/s12149-021-01641.
     PubMed     Abstract available
     
     
     
221. LEE SW, Jeong SY, Kim K, Kim SJ, et al
     Direct comparison of F-18 FDG PET/CT and MRI to predict pathologic response to neoadjuvant treatment in locally advanced rectal cancer: a meta-analysis.
     Ann Nucl Med. 2021 Jun 10. pii: 10.1007/s12149-021-01639.
     PubMed     Abstract available
     
     
     
222. KARAHAN SEN NP, Aksu A, Capa Kaya G
     A different overview of staging PET/CT images in patients with esophageal cancer: the role of textural analysis with machine learning methods.
     Ann Nucl Med. 2021 Jun 9. pii: 10.1007/s12149-021-01638.
     PubMed     Abstract available
     
     
     
223. IKOMA Y, Takuwa H, Nishino A, Maeda J, et al
     Measurement of changes in endogenous serotonin level by positron emission tomography with [(18)F]altanserin.
     Ann Nucl Med. 2021 Jun 8. pii: 10.1007/s12149-021-01633.
     PubMed     Abstract available
     
     
     
224. LI Y, Li Y, Huang Y, Wu X, et al
     Usefulness of (18)F-FDG PET/CT in treatment-naive patients with thymic squamous cell carcinoma.
     Ann Nucl Med. 2021 Jun 8. pii: 10.1007/s12149-021-01640.
     PubMed     Abstract available
     
     
     
225. LUO R, Wang L, Ye F, Wang YR, et al
     [(18)F]FEDAC translocator protein positron emission tomography-computed tomography for early detection of mitochondrial dysfunction secondary to myocardial ischemia.
     Ann Nucl Med. 2021 Jun 3. pii: 10.1007/s12149-021-01630.
     PubMed     Abstract available
     
     
     
226. NI YC, Tseng FP, Pai MC, Hsiao IT, et al
     Detection of Alzheimer's disease using ECD SPECT images by transfer learning from FDG PET.
     Ann Nucl Med. 2021 Jun 2. pii: 10.1007/s12149-021-01626.
     PubMed     Abstract available
     
     
     
227. FUKUNAGA T, Sanui K, Kadokami T, Sasaki M, et al
     Influences of radionuclides on left ventricular phase analysis of gated myocardial perfusion single-photon emission computed tomography images in ischemic heart disease.
     Ann Nucl Med. 2021;35:735-743.
     PubMed     Abstract available
     
     
     
228. QIU ZL, Saito S, Kayano D, Wakabayashi H, et al
     Comparison of the detecting capability between (123)I-mIBG and post-therapeutic (131)I-mIBG scintigraphy for curie scoring in patients with neuroblastoma after chemotherapy.
     Ann Nucl Med. 2021;35:649-661.
     PubMed     Abstract available
     
     
     
229. KAPADIA A, Desai P, Dmytriw A, Maralani P, et al
     In vivo detection of beta-amyloid at the nasal cavity and other skull-base sites: a retrospective evaluation of ADNI1/GO.
     Ann Nucl Med. 2021;35:728-734.
     PubMed     Abstract available
     
     
     May 2021
230. EVANGELISTA L, Zucchetta P, Moletta L, Serafini S, et al
     The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature review.
     Ann Nucl Med. 2021 May 28. pii: 10.1007/s12149-021-01629.
     PubMed     Abstract available
     
     
     
231. OTANI T, Otsuka H, Matsushita K, Otomi Y, et al
     Effect of different examination conditions on image quality and quantitative value of amyloid positron emission tomography using (18)F-flutemetamol.
     Ann Nucl Med. 2021 May 27. pii: 10.1007/s12149-021-01634.
     PubMed     Abstract available
     
     
     
232. ICHIKAWA H, Kawakami K, Onoguchi M, Shibutani T, et al
     Automatic quantification package (Hone Graph) for phantom-based image quality assessment in bone SPECT: computerized automatic classification of detectability.
     Ann Nucl Med. 2021 May 24. pii: 10.1007/s12149-021-01631.
     PubMed     Abstract available
     
     
     
233. TERESINSKA A, Wozniak O, Maciag A, Wnuk J, et al
     Quality and utility of [(123)I]I-metaiodobenzylguanidine cardiac SPECT imaging in nondiabetic postinfarction heart failure patients qualified for implantable cardioverter defibrillator.
     Ann Nucl Med. 2021 May 23. pii: 10.1007/s12149-021-01628.
     PubMed     Abstract available
     
     
     
234. HUNG GU, Zou J, He Z, Zhang X, et al
     Left-ventricular dyssynchrony in viable myocardium by myocardial perfusion SPECT is predictive of mechanical response to CRT.
     Ann Nucl Med. 2021 May 21. pii: 10.1007/s12149-021-01632.
     PubMed     Abstract available
     
     
     
235. KIM M, Gu W, Nakajima T, Higuchi T, et al
     Texture analysis of [(18)F]-fluorodeoxyglucose-positron emission tomography/computed tomography for predicting the treatment response of postoperative recurrent or metastatic oral squamous cell carcinoma treated with cetuximab.
     Ann Nucl Med. 2021 May 20. pii: 10.1007/s12149-021-01623.
     PubMed     Abstract available
     
     
     
236. CHIMURA M, Ohtani T, Sera F, Nakamoto K, et al
     Focal severe decrease in myocardial technetium-99 m sestamibi uptake indicates ventricular irreversibility in patients with dilated cardiomyopathy.
     Ann Nucl Med. 2021 May 18. pii: 10.1007/s12149-021-01625.
     PubMed     Abstract available
     
     
     
237. ASA S, Sonmezoglu K, Uslu-Besli L, Sahin OE, et al
     Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT.
     Ann Nucl Med. 2021 May 15. pii: 10.1007/s12149-021-01627.
     PubMed     Abstract available
     
     
     
238. HOTTA M, Minamimoto R, Gohda Y, Miwa K, et al
     Prognostic value of (18)F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgery.
     Ann Nucl Med. 2021 May 4. pii: 10.1007/s12149-021-01622.
     PubMed     Abstract available
     
     
     
239. KOMEK H, Can C, Guzel Y, Oruc Z, et al
     (68)Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the (18)F-FDG PET/CT.
     Ann Nucl Med. 2021 May 2. pii: 10.1007/s12149-021-01616.
     PubMed     Abstract available
     
     
     
240. LEE CH, Lim I, Woo SK, Kim W, et al
     Targeted alpha immunotherapy of CD20-positive B-cell lymphoma model: dosimetry estimate of (225)Ac-DOTA-rituximab using (64)Cu-DOTA-rituximab.
     Ann Nucl Med. 2021;35:639-647.
     PubMed     Abstract available
     
     
     
241. JUWEID ME, Alhouri A, Baniissa B, Rimawi D, et al
     Transient ischemic dilatation with adenosine (99m)Tc-sestamibi stress: prognostic significance in patients with normal myocardial perfusion.
     Ann Nucl Med. 2021;35:569-579.
     PubMed     Abstract available
     
     
     
242. HUANG HL, Ngam PI, Tan KM, Ng DCE, et al
     The exact Deauville score, NABS score and high SUVmax predicts outcome in extranodal natural killer/T-cell lymphoma.
     Ann Nucl Med. 2021;35:557-568.
     PubMed     Abstract available
     
     
     
243. TUNCEL M, Telli T, Tuncali MC, Karabulut E, et al
     Predictive factors of tumor sink effect: Insights from (177)Lu-Prostate-specific membrane antigen therapy.
     Ann Nucl Med. 2021;35:529-539.
     PubMed     Abstract available
     
     
     April 2021
244. KURISU S, Nitta K, Watanabe N, Ikenaga H, et al
     Associations of frontal QRS-T angle with left ventricular volume and function derived from ECG-gated SPECT in patients with advanced chronic kidney disease.
     Ann Nucl Med. 2021 Apr 18. pii: 10.1007/s12149-021-01596.
     PubMed     Abstract available
     
     
     
245. HOU Y, Guo K, Fan X, Shang K, et al
     Crossed cerebellar diaschisis: risk factors and prognostic value in focal cortical dysplasia by (18)F-FDG PET/CT.
     Ann Nucl Med. 2021 Apr 11. pii: 10.1007/s12149-021-01613.
     PubMed     Abstract available
     
     
     
246. HASHIMOTO F, Ito M, Ote K, Isobe T, et al
     Deep learning-based attenuation correction for brain PET with various radiotracers.
     Ann Nucl Med. 2021 Apr 3. pii: 10.1007/s12149-021-01611.
     PubMed     Abstract available
     
     
     
247. CHOI YJ, Jo K, Hwang SH, Jeong Y, et al
     Association between PD-L1 expression and (18)F-FDG uptake in ovarian cancer.
     Ann Nucl Med. 2021;35:415-420.
     PubMed     Abstract available
     
     
     
248. BANDO R, Otsuka H, Otani T, Matsuda N, et al
     A new quantitative index in the diagnosis of Parkinson syndrome by dopamine transporter single-photon emission computed tomography.
     Ann Nucl Med. 2021;35:504-513.
     PubMed     Abstract available
     
     
     
249. RADNIA A, Abdollahzadeh H, Teimourian B, Farahani MH, et al
     Development and characterization of an all-in-one gamma probe with auto-peak detection for sentinel lymph node biopsy based on NEMA NU3-2004 standard.
     Ann Nucl Med. 2021;35:438-446.
     PubMed     Abstract available
     
     
     March 2021
250. SHAO F, Zhao X, Toyama H, Ichihara T, et al
     Semi-quantitative assessment optimized the grading of pulmonary aspiration on salivagram in children.
     Ann Nucl Med. 2021;35:321-327.
     PubMed     Abstract available
     
     
     
251. DOTINGA M, van Dijk JD, Vendel BN, Slump CH, et al
     Clinical value of machine learning-based interpretation of I-123 FP-CIT scans to detect Parkinson's disease: a two-center study.
     Ann Nucl Med. 2021;35:378-385.
     PubMed     Abstract available
     
     
     February 2021
252. SAKATANI T, Nakajima K, Fujita H, Nishimura T, et al
     Cardiovascular event risk estimated after coronary revascularization and optimal medical therapy: J-ACCESS4 prognostic study.
     Ann Nucl Med. 2021;35:241-252.
     PubMed     Abstract available
     
     
     
253. KANG JY, Lee MY, Kim YH
     Associations of physiologic myocardial (18)F-FDG uptake with fasting duration, HbA1c, and regular exercise.
     Ann Nucl Med. 2021;35:195-202.
     PubMed     Abstract available
     
     
     
254. KONISHI K, Ishiba R, Ikenohira T, Asao T, et al
     The relationship between the quantitative evaluation of thyroid bed uptake and the disappearance of accumulation in adjuvant radioactive iodine therapy for differentiated thyroid cancer.
     Ann Nucl Med. 2021;35:159-166.
     PubMed     Abstract available
     
     
     January 2021
255. PARGHANE RV, Talole S, Basu S
     (131)I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with (177)Lu-DOTATATE peptide receptor radionuclide therapy.
     Ann Nucl Med. 2021;35:92-101.
     PubMed     Abstract available
     
     
     
256. SHIN S, Nam HY, Lee MJ, Pak K, et al
     Effect of sex on aging-related decline of dopamine transporter in healthy subjects.
     Ann Nucl Med. 2021;35:76-82.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.